PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Unreasonable prescription costs leading to life-threatening asthma attacks

Asthma UK has revealed that people with asthma are rationing their medication due to prescription costs and it’s causing avoidable asthma attacks and extra hospital admissions.

A new report by the charity has claimed that more than a million people in England are having to ‘pay to breathe’ and are at risk of having a life-threatening asthma attack because they are struggling to pay for their asthma prescriptions.

The news comes in light of a new campaign to stop unfair asthma prescription charges, which has revealed that of the 2.3 million people in England with asthma who have to pay for prescriptions, more than three quarters say they struggle to afford them.

‘Paying to breathe: Why unfair asthma prescription charges must be stopped’, which includes research with over 9,000 people with asthma in England, also revealed that more than half (57%) of people with asthma who pay for their medication have skipped taking it because of the cost, which adds up to an estimated 1.3 million people.

Of these, a quarter said it led to an asthma attack, and more than one in 10 said they had needed hospital treatment.

Dr Samantha Walker, director of research and policy at Asthma UK commented: “It is unfair that millions of people with asthma are getting a raw deal, paying unfair costs for their medicine just to stay well. No one should have to pay to breathe.

“Asthma is a serious condition that kills three people every day in the UK and the best way for people to stay well is to take their life-saving medication, often for their entire life.

“When people are struggling financially they may feel they simply cannot afford to pay for the medication. By not taking it, they are at risk of being hospitalised or even dying from an asthma attack.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026